B. L. Abbott, Advances in the diagnosis and treatment of chronic lymphocytic leukemia, Clin Adv Hematol Oncol, vol.2, pp.448-454, 2004.

B. L. Abbott, Chronic lymphocytic leukemia: recent advances in diagnosis and treatment, Oncologist, vol.11, pp.21-30, 2006.

A. L. Abujamra, R. A. Spanjaard, I. Akinsheye, X. Zhao, D. V. Faller et al., Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism, Virology, vol.345, pp.390-403, 2006.
DOI : 10.1016/j.virol.2005.10.003

URL : https://doi.org/10.1016/j.virol.2005.10.003

A. Aderem and R. J. Ulevitch, Toll-like receptors in the induction of the innate immune response, Nature, vol.406, pp.782-787, 2000.

S. Akira, Mammalian Toll-like receptors, Curr Opin Immunol, vol.15, pp.5-11, 2003.

S. Akira, TLR signaling, Curr Top Microbiol Immunol, vol.311, pp.1-16, 2006.
DOI : 10.1007/3-540-32636-7_1

S. Akira and K. Takeda, Toll-like receptor signalling, Nat Rev Immunol, vol.4, pp.499-511, 2004.

A. Alessandrini, D. S. Chiaur, and M. Pagano, Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation, Leukemia, vol.11, pp.342-345, 1997.

L. Alexopoulou, A. C. Holt, R. Medzhitov, and R. A. Flavell, Recognition of doublestranded RNA and activation of NF-kappaB by Toll-like receptor 3, Nature, vol.413, pp.732-738, 2001.

L. Alexopoulou, V. Thomas, M. Schnare, Y. Lobet, J. Anguita et al., Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1-and TLR2-deficient mice, Nat Med, vol.8, pp.878-884, 2002.
DOI : 10.1038/nm732

, Apoptosis Assay Methods : Methods for studying apoptosis in individual cells Disponible sur

A. Asea, M. Rehli, E. Kabingu, J. A. Boch, O. Bare et al., Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4, J Biol Chem, vol.277, pp.15028-15034, 2002.

W. C. Au, P. A. Moore, D. W. Lafleur, B. Tombal, and P. M. Pitha, Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes, J Biol Chem, vol.273, pp.29210-29217, 1998.

A. Badros, B. Barlogie, C. Morris, R. Desikan, S. R. Martin et al., High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor 221 lymphocyte infusions, Blood, vol.97, pp.2574-2579, 2001.
DOI : 10.1182/blood.v97.9.2574

URL : http://www.bloodjournal.org/content/97/9/2574.full.pdf

R. M. Barge, S. Osanto, W. A. Marijt, C. W. Starrenburg, W. E. Fibbe et al., Minimal GVHD following in-vitro T celldepleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors, Exp Hematol, vol.31, pp.865-872, 2003.

B. J. Barnes, P. A. Moore, and P. M. Pitha, Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes, J Biol Chem, vol.276, pp.23382-23390, 2001.

M. Barragan, B. Bellosillo, C. Campas, D. Colomer, G. Pons et al., Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells, Blood, vol.99, pp.2969-2976, 2002.

M. Barragan, M. De-frias, D. Iglesias-serret, C. Campas, E. Castano et al., Regulation of, 2006.

, Akt/PKB by phosphatidylinositol 3-kinase-dependent and-independent pathways in Bcell chronic lymphocytic leukemia cells: role of protein kinase C(Tabeta et al.), J Leukoc Biol, vol.80, pp.1473-1479

H. Bastians, F. M. Townsley, and J. V. Ruderman, The cyclin-dependent kinase inhibitor p27(Kip1) induces N-terminal proteolytic cleavage of cyclin A, Proc Natl Acad Sci U S A, vol.95, pp.15374-15381, 1998.

B. Bauer, M. Jenny, F. Fresser, F. Uberall, and G. Baier, AKT1/PKBalpha is recruited to lipid rafts and activated downstream of PKC isotypes in CD3-induced T cell signaling, FEBS Lett, vol.541, pp.155-162, 2003.

M. Bauer, K. Heeg, H. Wagner, and G. B. Lipford, DNA activates human immune cells through a CpG sequence-dependent manner, Immunology, vol.97, pp.699-705, 1999.

S. Bauer, C. J. Kirschning, H. Hacker, V. Redecke, S. Hausmann et al., Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition, Proc Natl Acad Sci U S A, vol.98, pp.9237-9242, 2001.

J. K. Bell, G. E. Mullen, C. A. Leifer, A. Mazzoni, D. R. Davies et al., Leucine-rich repeats and pathogen recognition in Toll-like receptors, Trends Immunol, vol.24, pp.528-533, 2003.

K. Bellmann, J. Martel, D. J. Poirier, M. M. Labrie, and J. Landry, Downregulation of the PI3K/Akt survival pathway in cells with deregulated expression of c-Myc, Apoptosis, vol.11, pp.1311-1319, 2006.

N. L. Bernasconi, N. Onai, and A. Lanzavecchia, A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells, Blood, vol.101, pp.4500-4504, 2003.

A. Besse, B. Lamothe, A. D. Campos, W. K. Webster, U. Maddineni et al., TAK1-dependent signaling requires functional interaction with TAB2/TAB3, J Biol Chem, vol.282, pp.3918-3928, 2007.

M. Beyer, M. Kochanek, K. Darabi, A. Popov, M. Jensen et al., Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine, Blood, vol.106, pp.2018-2025, 2005.

K. Bieback, E. Lien, I. M. Klagge, E. Avota, J. Schneider-schaulies et al., , 2002.

, Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling, J Virol, vol.76, pp.8729-8736

J. L. Binet, A. Auquier, G. Dighiero, C. Chastang, H. Piguet et al., A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis, Cancer, vol.48, pp.198-206, 1981.

J. L. Binet, K. Maloum, V. Leblond, L. Sutton, J. Gabarre et al., Leucémie lymphoïde chronique. Source : Cancers : évaluation, traitement et surveillance, Andrieu J.M., Colonna P, 1997.

, Disponible sur

A. Biragyn, P. A. Ruffini, C. A. Leifer, E. Klyushnenkova, A. Shakhov et al., , 2002.

, Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2, Science, vol.298, pp.1025-1029

P. Björck and P. W. Kincade, Cutting Edge: CD19+ Pro-B Cells Can Give Rise to Dendritic Cells In Vitro, J Immunol, vol.161, pp.5795-5799, 1998.

D. Blaise, G. Gravis, and D. Maraninchi, Long-term follow-up of T-cell depletion for bone marrow transplantation, Lancet, vol.341, pp.51-52, 1993.

J. C. Boldrick, A. A. Alizadeh, M. Diehn, S. Dudoit, C. L. Liu et al., Stereotyped and specific gene expression programs in human innate immune responses to bacteria, Proc Natl Acad Sci, vol.223, 2002.

, U S A, vol.99, pp.972-977

L. C. Borish and J. W. Steinke, ) 2. Cytokines and chemokines, J Allergy Clin Immunol, vol.111, pp.460-475, 2003.

R. L. Bottrel, Y. Yang, D. E. Levy, M. Tomai, and L. F. Reis, The Immune Response Modifier Imiquimod Requires STAT-1 for induction of Interferon, InterferonStimulated Genes, and Interleukin-6, Antimicrob Agents Chemother, vol.43, pp.856-861, 1999.

E. Bourke, D. Bosisio, J. Golay, N. Polentarutti, and A. Mantovani, The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells, Blood, vol.102, pp.956-963, 2003.

A. L. Bowen, A. Zomas, E. Emmett, E. Matutes, M. J. Dyer et al., Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia, Br J Haematol, vol.96, pp.617-619, 1997.

A. Boyum, Isolation of lymphocytes, granulocytes and macrophages, Scand J Immunol Suppl, vol.5, pp.9-15, 1976.

K. Branson, R. Chopra, P. D. Kottaridis, G. Mcquaker, A. Parker et al., Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies, J Clin Oncol, vol.20, pp.4022-4031, 2002.

R. Buhmann, A. Nolte, D. Westhaus, B. Emmerich, and M. Hallek, CD40-activated Bcell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells, Blood, vol.93, 1992.

K. Burns, J. Clatworthy, L. Martin, F. Martinon, C. Plumpton et al., Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor, Nat Cell Biol, vol.2, pp.346-351, 2000.

J. C. Byrd, S. Stilgenbauer, and I. W. Flinn, Chronic lymphocytic leukemia, Hematology Am Soc Hematol Educ Program, pp.163-183, 2004.

A. M. Cacace, M. Ueffing, A. Philipp, E. K. Han, W. Kolch et al., PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase, Oncogene, vol.13, pp.2517-2526, 1996.

F. Caligaris-cappio, A. Cignetti, L. Granziero, and P. Ghia, Chronic lymphocytic leukaemia: a model for investigating potential new targets for the therapy of indolent Activation of Raf-1 Signaling by Protein Kinase C through a Mechanism Involving Raf Kinase Inhibitory Protein, J Biol Chem, vol.278, pp.13061-13068, 2002.

M. P. Corradi, D. F. Jelinek, J. E. Ramberg, and P. E. Lipsky, Development of a cell with dendritic morphology from a precursor of B lymphocyte lineage, J Immunol, vol.138, pp.2075-2081, 1987.

C. P. Costa, C. J. Kirschning, D. Busch, S. Durr, L. Jennen et al., Role of chlamydial heat shock protein 60 in the stimulation of innate immune cells by Chlamydia pneumoniae, Eur J Immunol, vol.32, pp.2460-2470, 2002.

M. Crespo, F. Bosch, N. Villamor, B. Bellosillo, D. Colomer et al., ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia, N Engl J Med, vol.348, pp.1764-1775, 2003.

R. N. Damle, T. Wasil, F. Fais, F. Ghiotto, A. Valetto et al., Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia, Blood, vol.94, pp.1840-1847, 1999.

H. C. Dan, M. Sun, S. Kaneko, R. I. Feldman, S. V. Nicosia et al., Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP), J Biol Chem, vol.279, pp.5405-5412, 2004.

P. Dasari, I. C. Nicholson, G. Hodge, G. W. Dandie, and H. Zola, Expression of toll-like receptors on B lymphocytes, Cell Immunol, vol.236, pp.140-145, 2005.

S. R. Datta, A. Brunet, and M. E. Greenberg, Cellular survival: a play in three Akts, Genes Dev, vol.13, pp.2905-2927, 1999.

S. R. Datta, H. Dudek, X. Tao, S. Masters, H. Fu et al., Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery, Cell, vol.91, pp.231-241, 1997.

S. Deaglio, A. Capobianco, L. Bergui, J. Durig, F. Morabito et al., CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells, Blood, vol.102, pp.2146-2155, 2003.

T. Decker, F. Schneller, S. Hipp, C. Miething, T. Jahn et al., Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27, Leukemia, vol.16, pp.327-334, 2002.

T. Decker, F. Schneller, M. Kronschnabl, T. Dechow, G. B. Lipford et al., Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype, Exp Hematol, vol.28, pp.558-568, 2000.

T. Decker, F. Schneller, T. Sparwasser, T. Tretter, G. B. Lipford et al., Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells, Blood, vol.95, pp.999-1006, 2000.

M. Degan, M. Rupolo, M. D. Bo, A. Stefanon, R. Bomben et al., Mutational status of IgVH genes consistent with antigen-driven selection but not percent of mutations has prognostic impact in B-cell chronic lymphocytic leukemia, Clin Lymphoma, vol.5, pp.123-126, 2004.

J. Delgado, K. Thomson, N. Russell, J. Ewing, W. Stewart et al., Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study, Blood, vol.107, pp.1724-1730, 2006.

L. Deng, C. Wang, E. Spencer, L. Yang, A. Braun et al., Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain, Cell, vol.103, pp.351-361, 2000.

F. P. Di-celle, S. Mariani, L. Riera, A. Stacchini, G. Reato et al., Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion, Blood, vol.87, pp.4382-4389, 1996.

P. F. Di-celle, A. Carbone, D. Marchis, D. Zhou, S. Sozzani et al., Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein, Blood, vol.84, pp.220-228, 1994.

F. Dicker, S. Schnittger, T. Haferlach, W. Kern, and C. Schoch, Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: A study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression, Blood, vol.108, pp.3152-3160, 2006.

B. Didona, R. Benucci, P. Amerio, F. Canzona, O. Rienzo et al., Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara), Br J Dermatol, vol.150, pp.1198-1201, 2004.

S. S. Diebold, T. Kaisho, H. Hemmi, S. Akira, and C. Reis-e-sousa, Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA, Science, vol.303, pp.1529-1531, 2004.

S. Diehl and M. Rincon, The two faces of IL-6 on Th1/Th2 differentiation, Mol Immunol, vol.39, pp.531-536, 2002.

G. Dighiero, Is chronic lymphocytic leukemia one disease?, Haematologica, vol.87, pp.1233-1235, 2002.

G. Dighiero, CLL Biology and Prognosis, Hematology Am Soc Hematol Educ Program, pp.278-284, 2005.

G. Dighiero, E. Bodega, R. Mayzner, and J. L. Binet, Individual cell-by-cell quantitation of lymphocyte surface membrane Ig in normal and CLL lymphocyte and during ontogeny of mouse B lymphocytes by immunoperoxidase assay, Blood, vol.55, pp.93-100, 1980.

G. Dighiero, K. Maloum, B. Desablens, B. Cazin, M. Navarro et al., Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia, N Engl J Med, vol.338, pp.1506-1514, 1998.

G. Dighiero, P. Travade, S. Chevret, P. Fenaux, C. Chastang et al., B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL, Blood, vol.78, pp.1901-1914, 1991.

V. M. Dirsch, H. Stuppner, and A. M. Vollmar, Helenalin Triggers a CD95 Death Receptor-independent Apoptosis That Is Not Affected by Overexpression of Bcl-xL or Bcl-2, Cancer Res, vol.61, pp.5817-5823, 2001.

D. H. Dockrell and G. R. Kinghorn, Imiquimod and resiquimod as novel immunomodulators, J Antimicrob Chemother, vol.48, pp.751-755, 2001.

H. Döhner, K. Fischer, M. Bentz, K. Hansen, A. Benner et al., gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias, Blood, vol.85, pp.1580-1589, 1995.

H. Döhner, S. Stilgenbauer, A. Benner, E. Leupolt, A. Krober et al., Genomic aberrations and survival in chronic lymphocytic leukemia, N Engl J Med, vol.343, pp.1910-1916, 2000.

M. Dono, G. Cerruti, and S. Zupo, The CD5+ B-cell, Int J Biochem Cell Biol, vol.36, pp.2105-2111, 2004.
DOI : 10.1016/j.biocel.2004.05.017

X. Du, A. Poltorak, Y. Wei, and B. Beutler, Three novel mammalian toll-like receptors: gene structure, expression, and evolution, Eur Cytokine Netw, vol.11, pp.362-371, 2000.

C. D. Dumitru, J. D. Ceci, C. Tsatsanis, D. Kontoyiannis, K. Stamatakis et al., TNFalpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway, Cell, vol.103, pp.1071-1083, 2000.
DOI : 10.1016/s0092-8674(00)00210-5

URL : https://doi.org/10.1016/s0092-8674(00)00210-5

B. Dybdahl, A. Wahba, E. Lien, T. H. Flo, A. Waage et al., Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4, Circulation, vol.105, pp.685-690, 2002.
DOI : 10.1161/hc0602.103617

A. Eaton-bassiri, S. B. Dillon, M. Cunningham, M. A. Rycyzyn, J. Mills et al., Toll-like receptor 9 can be expressed at the cell surface of distinct populations of tonsils and human peripheral blood mononuclear cells, Infect Immun, vol.72, pp.7202-7211, 2004.

H. Echchakir, M. Bagot, G. Dorothee, D. Martinvalet, L. Gouvello et al., Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis, J Invest Dermatol, vol.115, pp.74-80, 2000.
DOI : 10.1046/j.1523-1747.2000.00995.x

URL : https://doi.org/10.1046/j.1523-1747.2000.00995.x

B. F. Eichhorst, R. Busch, G. Hopfinger, R. Pasold, M. Hensel et al., Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia, Blood, vol.107, pp.885-891, 2006.

S. Fagarasan and T. Honjo, T-Independent immune response: new aspects of B cell biology, Science, vol.290, pp.89-92, 2000.
DOI : 10.1126/science.290.5489.89

L. Fayad, M. J. Keating, J. M. Reuben, S. O'brien, B. N. Lee et al., Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome, Blood, vol.97, pp.256-263, 2001.
DOI : 10.1182/blood.v97.1.256

URL : http://www.bloodjournal.org/content/97/1/256.full.pdf

E. R. Fearon, D. M. Pardoll, T. Itaya, P. Golumbek, H. I. Levitsky et al., Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response, Cell, vol.60, pp.397-403, 1990.

A. R. Ferguson, M. E. Youd, and R. B. Corley, Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells, Int Immunol, vol.16, pp.1411-1422, 2004.
DOI : 10.1093/intimm/dxh142

URL : https://academic.oup.com/intimm/article-pdf/16/10/1411/2174147/dxh142.pdf

I. Ferrer, B. Friguls, E. Dalfo, and A. M. Planas, Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia, Acta Neuropathol (Berl), vol.105, pp.425-437, 2003.

K. A. Fitzgerald, D. C. Rowe, B. J. Barnes, D. R. Caffrey, A. Visintin et al., LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF, J Exp Med, vol.198, pp.1043-1055, 2003.
DOI : 10.1084/jem.20031023

URL : http://jem.rupress.org/content/198/7/1043.full.pdf

I. W. Flinn and M. R. Grever, Chronic lymphocytic leukemia, Cancer Treat Rev, vol.22, pp.1-13, 1996.

R. Foa, M. T. Fierro, P. Lusso, D. Raspadori, M. L. Ferrando et al., Reduced natural killer T-cells in B-cell chronic lymphocytic leukaemia identified by three monoclonal antibodies: Leu-11, A10, AB8.28, Br J Haematol, vol.62, pp.151-154, 1986.
DOI : 10.1111/j.1365-2141.1986.tb02911.x

, Natural history of stage A chronic lymphocytic leukaemia untreated patients, Br J Haematol, vol.76, pp.45-57, 1990.

V. Fulci, S. Chiaretti, M. Goldoni, G. Azzalin, N. Carucci et al.,

F. R. Mauro, P. Landgraf, T. Tuschl, D. B. Weir, M. Chien et al., Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia, Blood, vol.109, pp.4944-4951, 2007.

K. Funami, M. Matsumoto, H. Oshiumi, T. Akazawa, A. Yamamoto et al., The cytoplasmic 'linker region' in Toll-like receptor 3 controls receptor localization and signaling, Int Immunol, vol.16, pp.1143-1154, 2004.
DOI : 10.1093/intimm/dxh115

URL : https://academic.oup.com/intimm/article-pdf/16/8/1143/2572602/dxh115.pdf

M. Galdiero, M. Galdiero, E. Finamore, F. Rossano, M. Gambuzza et al., Haemophilus influenzae porin induces Toll-like receptor 2-mediated cytokine production in human monocytes and mouse macrophages, Infect Immun, vol.72, pp.1204-1209, 2004.
DOI : 10.1128/iai.72.2.1204-1209.2004

URL : https://iai.asm.org/content/72/2/1204.full.pdf

F. Gantner, P. Hermann, K. Nakashima, S. Matsukawa, K. Sakai et al., CD40-dependent and-independent activation of human tonsil B cells by CpG oligodeoxynucleotides, Eur J Immunol, vol.33, pp.1576-1585, 2003.
DOI : 10.1002/eji.200323444

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.200323444

F. G. Gao, V. Khammanivong, W. J. Liu, G. R. Leggatt, I. H. Frazer et al., Antigen-specific CD4+ T-cell help is required to activate a memory CD8+ T cell to a fully functional tumor killer cell, Cancer Res, vol.62, pp.6438-6441, 2002.

J. Geisse, I. Caro, J. Lindholm, L. Golitz, P. Stampone et al., Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies, J Am Acad Dermatol, vol.50, pp.722-733, 2004.

J. K. Geisse, P. Rich, A. Pandya, K. Gross, K. Andres et al., , 2002.

, Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a doubleblind, randomized, vehicle-controlled study, J Am Acad Dermatol, vol.47, pp.390-398

P. Ghia and F. Caligaris-cappio, The origin of B-cell chronic lymphocytic leukemia, Semin Oncol, vol.33, pp.150-156, 2006.

M. H. Gilleece and T. M. Dexter, Effect of Campath-1H antibody on human hematopoietic progenitors in vitro, Blood, vol.82, pp.807-812, 1993.

R. L. Giuntoli, J. Lu, H. Kobayashi, R. Kennedy, and E. Celis, Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function, Clin Cancer Res, vol.8, pp.922-931, 2002.

R. A. Goldsby, T. J. Kindt, and B. A. Osborne, , 2000.

K. Gomi, K. Kawasaki, Y. Kawai, M. Shiozaki, and M. Nishijima, Toll-like receptor 4MD-2 complex mediates the signal transduction induced by flavolipin, an amino acidcontaining lipid unique to Flavobacterium meningosepticum, J Immunol, vol.168, pp.2939-2943, 2002.
DOI : 10.4049/jimmunol.168.10.5376

URL : http://www.jimmunol.org/content/168/10/5376.1.full.pdf

A. Grakoui, S. K. Bromley, C. Sumen, M. M. Davis, A. S. Shaw et al., The immunological synapse: a molecular machine controlling T cell activation, Science, vol.285, pp.221-227, 1999.

C. Grandjenette, A. Kennel, F. Massin, G. C. Faure, M. C. Bene et al., Measurement of immunoglobulins G, A, and M levels in B-lymphocytes culture, J Immunoassay Immunochem, vol.26, pp.303-311, 2005.

J. G. Gribben, Stem-cell transplantation in chronic lymphocytic leukaemia, Best Pract Res Clin Haematol, vol.20, pp.513-527, 2007.

C. Guiducci, G. Ott, J. H. Chan, E. Damon, C. Calacsan et al., Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation, J Exp Med, vol.203, 1999.

L. Guillot, V. Balloy, F. X. Mccormack, D. T. Golenbock, M. Chignard et al., Cutting edge: the immunostimulatory activity of the lung surfactant protein-A 232 involves Toll-like receptor 4, J Immunol, vol.168, pp.5989-5992, 2002.

M. Gursel, I. Gursel, H. S. Mostowski, and D. M. Klinman, CXCL16 influences the nature and specificity of CpG-induced immune activation, J Immunol, vol.177, pp.1575-1580, 2006.

H. Häcker, V. Redecke, B. Blagoev, I. Kratchmarova, L. C. Hsu et al., Specificity in Tolllike receptor signalling through distinct effector functions of TRAF3 and TRAF6, Nature, vol.439, pp.204-207, 2006.

A. M. Hajjar, D. S. O'mahony, A. Ozinsky, D. M. Underhill, A. Aderem et al., Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin, J Immunol, vol.166, pp.15-19, 2001.
DOI : 10.4049/jimmunol.166.1.15

URL : http://www.jimmunol.org/content/166/1/15.full.pdf

G. Hale, S. Cobbold, N. Novitzky, D. Bunjes, R. Willemze et al., CAMPATH-1 antibodies in stem-cell transplantation, Cytotherapy, vol.3, pp.145-164, 2001.
DOI : 10.1080/146532401753173981

M. Hallek, I. Langenmayer, C. Nerl, W. Knauf, H. Dietzfelbinger et al., Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia, Blood, vol.93, pp.1732-1737, 1999.

M. Hallek, L. Wanders, M. Ostwald, R. Busch, R. Senekowitsch et al., Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma, Leuk Lymphoma, vol.22, pp.439-447, 1996.

T. J. Hamblin, Z. Davis, A. Gardiner, D. G. Oscier, and F. K. Stevenson, Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia, Blood, vol.94, pp.1848-1854, 1999.

T. J. Hamblin, J. A. Orchard, A. Gardiner, D. G. Oscier, Z. Davis et al., Immunoglobulin V genes and CD38 expression in CLL, Blood, vol.95, pp.2455-2457, 2000.

T. J. Hamblin, J. A. Orchard, R. E. Ibbotson, Z. Davis, P. W. Thomas et al., CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease, Blood, vol.99, pp.1023-1029, 2002.

M. Hanada, D. Delia, A. Aiello, E. Stadtmauer, and J. C. Reed, ) bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia, Blood, vol.82, pp.1820-1828, 1993.

H. Harada, B. Quearry, A. Ruiz-vela, and S. J. Korsmeyer, Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity, Proc Natl Acad Sci U S A, vol.101, pp.15313-15317, 2004.
DOI : 10.1073/pnas.0406837101

URL : http://www.pnas.org/content/101/43/15313.full.pdf

S. Harig, M. Witzens, A. M. Krackhardt, A. Trojan, P. Barrett et al., Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues, Blood, vol.98, pp.2999-3005, 2001.
DOI : 10.1182/blood.v98.10.2999

URL : http://www.bloodjournal.org/content/98/10/2999.full.pdf

N. L. Harris, E. S. Jaffe, J. Diebold, G. Flandrin, H. K. Muller-hermelink et al., Lymphoma classification-from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms, Ann Oncol, vol.11, pp.3-10, 2000.
DOI : 10.1093/annonc/11.suppl_1.s3

URL : https://academic.oup.com/annonc/article-pdf/11/suppl_1/S3/7724526/11-suppl_1-S3.pdf

N. L. Harris, E. S. Jaffe, H. Stein, P. M. Banks, J. K. Chan et al., A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group, Blood, vol.84, pp.1361-1392, 1994.

G. Hartmann and A. M. Krieg, Mechanism and function of a newly identified CpG DNA motif in human primary B cells, J Immunol, vol.164, pp.944-953, 2000.

U. Hasan, C. Chaffois, C. Gaillard, V. Saulnier, E. Merck et al., Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88, J Immunol, vol.174, pp.2942-2950, 2005.
DOI : 10.4049/jimmunol.174.5.2942

URL : http://www.jimmunol.org/content/174/5/2942.full.pdf

C. Hashimoto, K. L. Hudson, and K. V. Anderson, The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein, Cell, vol.52, pp.269-279, 1988.

F. Hayashi, K. D. Smith, A. Ozinsky, T. R. Hawn, E. C. Yi et al., The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5, Nature, vol.410, pp.1099-1103, 2001.
DOI : 10.1038/35074106

F. Heil, H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning et al., Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8, Science, vol.303, pp.1526-1529, 2004.
DOI : 10.1126/science.1093620

H. Hemmi, T. Kaisho, O. Takeuchi, S. Sato, H. Sanjo et al., Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway, Nat Immunol, vol.3, pp.196-200, 2002.
DOI : 10.1038/ni758

H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato et al., A Toll-like receptor recognizes bacterial DNA, Nature, vol.408, pp.740-745, 2000.
DOI : 10.1038/35047123

H. Hemmi, O. Takeuchi, S. Sato, M. Yamamoto, T. Kaisho et al., The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection, J Exp Med, vol.199, pp.1641-1650, 2004.

M. O. Hengartner, The biochemistry of apoptosis, Nature, vol.407, pp.770-776, 2000.
DOI : 10.1038/35037710

J. A. Hernandez, K. J. Land, and R. W. Mckenna, Leukemias, myeloma, and other lymphoreticular neoplasms, Cancer, vol.75, pp.381-394, 1995.

M. Hirschfeld, J. J. Weis, V. Toshchakov, C. A. Salkowski, M. J. Cody et al.,

N. Qureshi, S. M. Michalek, and S. N. Vogel, Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages, Infect Immun, vol.69, pp.1477-1482, 2001.

J. Hiscott, P. Pitha, P. Genin, H. Nguyen, C. Heylbroeck et al., Triggering the interferon response: the role of IRF-3 transcription factor, J Interferon Cytokine Res, vol.19, pp.1-13, 1999.

H. Hochrein, B. Schlatter, M. O'keeffe, C. Wagner, F. Schmitz et al., Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and-independent pathways, Proc Natl Acad Sci U S A, vol.101, pp.11416-11421, 2004.
DOI : 10.1073/pnas.0403555101

URL : http://europepmc.org/articles/pmc509215?pdf=render

K. Hoebe, E. M. Janssen, S. O. Kim, L. Alexopoulou, R. A. Flavell et al., Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways, Nat Immunol, vol.4, pp.1223-1229, 2003.

J. A. Hoffmann, The immune response of Drosophila, Nature, vol.426, pp.33-38, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00095084

K. Honda, Y. Ohba, H. Yanai, H. Negishi, T. Mizutani et al., Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction, Nature, vol.434, pp.1035-1040, 2005.

K. Honda, H. Yanai, H. Negishi, M. Asagiri, M. Sato et al., IRF-7 is the master regulator of type-I interferon-dependent immune responses, Nature, vol.434, pp.772-777, 2005.

P. A. Hopkins and S. Sriskandan, Mammalian Toll-like receptors: to immunity and beyond, Clin Exp Immunol, vol.140, pp.395-407, 2005.
DOI : 10.1111/j.1365-2249.2005.02801.x

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1809390

T. Horng, G. M. Barton, R. A. Flavell, and R. Medzhitov, The adaptor molecule TIRAP 235 provides signalling specificity for Toll-like receptors, Nature, vol.420, pp.329-333, 2002.
DOI : 10.1038/nature01180

V. Hornung, S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdörfer et al., Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides, J Immunol, vol.168, pp.4531-4537, 2002.

K. Hoshino, O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa et al., Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product, J Immunol, vol.162, pp.3749-3752, 1999.

T. Hoy, Flow Cytometry and Cell Sorting: An Introduction Disponible sur, p.11, 2005.

P. Hu, Z. Han, A. D. Couvillon, and J. H. Exton, Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death, J Biol Chem, vol.279, pp.49420-49429, 2004.

K. Hung, R. Hayashi, A. Lafond-walker, C. Lowenstein, D. Pardoll et al., The central role of CD4(+) T cells in the antitumor immune response, J Exp Med, vol.188, pp.2357-2368, 1998.

S. Ibrahim, M. Keating, K. A. Do, S. O'brien, Y. O. Huh et al., CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia, Blood, vol.98, pp.181-186, 2001.
DOI : 10.1182/blood.v98.1.181

URL : http://www.bloodjournal.org/content/98/1/181.full.pdf

J. L. Imler and J. A. Hoffmann, Toll receptors in innate immunity, Trends Cell Biol, vol.11, pp.304-311, 2001.

T. Ishitani, G. Takaesu, J. Ninomiya-tsuji, H. Shibuya, R. B. Gaynor et al., Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling, Embo J, vol.22, pp.6277-6288, 2003.

A. Iwasaki and R. Medzhitov, Toll-like receptor control of the adaptive immune responses, Nat Immunol, vol.5, pp.987-995, 2004.

B. Jahrsdörfer, G. Hartmann, E. Racila, W. Jackson, L. Muhlenhoff et al., CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens, J Leukoc Biol, vol.69, pp.81-88, 2001.

B. Jahrsdörfer, L. Muhlenhoff, S. E. Blackwell, M. Wagner, H. Poeck et al., , p.236, 2005.

, lymphomas differ in their responsiveness to CpG oligodeoxynucleotides, Clin Cancer Res, vol.11, pp.1490-1499

B. Jahrsdörfer, J. E. Wooldridge, S. E. Blackwell, C. M. Taylor, T. S. Griffith et al., Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells, J Leukoc Biol, vol.77, pp.378-387, 2005.

C. A. Janeway, . Jr, and R. Medzhitov, Innate immune recognition, Annu Rev Immunol, vol.20, pp.197-216, 2002.

C. A. Janeway, P. Travers, M. Walport, and M. Shlomchik, Immuno biology, the immune system in health and disease, 2001.

G. B. Johnson, G. J. Brunn, Y. Kodaira, and J. L. Platt, Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4, J Immunol, vol.168, pp.5233-5239, 2002.

S. Johnson, A. G. Smith, H. Loffler, E. Osby, G. Juliusson et al., Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL, Lancet, vol.347, pp.1432-1438, 1996.

A. D. Judge, V. Sood, J. R. Shaw, D. Fang, K. Mcclintock et al., Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA, Nat Biotechnol, vol.23, pp.457-462, 2005.

G. Juliusson and G. Gahrton, Chromosome aberrations in B-cell chronic lymphocytic leukemia. Pathogenetic and clinical implications, Cancer Genet Cytogenet, vol.45, pp.143-160, 1990.

P. Juo, C. J. Kuo, S. E. Reynolds, R. F. Konz, J. Raingeaud et al., Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases, Mol Cell Biol, vol.17, pp.24-35, 1997.

M. Jurk, B. Schulte, A. Kritzler, B. Noll, E. Uhlmann et al., C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level, Immunobiology, vol.209, pp.141-154, 2004.

T. Kaisho and S. Akira, Pleiotropic function of Toll-like receptors, Microbes Infect, vol.6, pp.1388-1394, 2004.

N. Kalil and B. D. Cheson, Chronic lymphocytic leukemia, Oncologist, vol.4, pp.352-369, 1999.

L. P. Kane, J. Lin, and A. Weiss, Signal transduction by the TCR for antigen, Curr Opin Immunol, vol.12, pp.242-249, 2000.

S. H. Kaufmann and G. J. Gores, Apoptosis in cancer: cause and cure, Bioessays, vol.22, pp.1007-1017, 2000.

M. Kawada, S. Yamagoe, Y. Murakami, K. Suzuki, S. Mizuno et al., Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway, Oncogene, vol.15, pp.629-637, 1997.

T. Kawai and S. Akira, Innate immune recognition of viral infection, Nat Immunol, vol.7, pp.131-137, 2006.

T. Kawai and S. Akira, TLR signaling, Cell Death Differ, vol.13, pp.816-825, 2006.

T. Kawai, S. Sato, K. J. Ishii, C. Coban, H. Hemmi et al., Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6, Nat Immunol, vol.5, pp.1061-1068, 2004.

T. Kawai, O. Takeuchi, T. Fujita, J. Inoue, P. F. Muhlradt et al., Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes, J Immunol, vol.167, pp.5887-5894, 2001.

Y. Kawakami, H. Nishimoto, J. Kitaura, M. Maeda-yamamoto, R. M. Kato et al.,

R. Leitges, M. Rawlings, D. J. Kawakami, and T. , Protein kinase C betaII regulates Akt phosphorylation on Ser-473 in a cell type-and stimulus-specific fashion, J Biol Chem, vol.279, pp.47720-47725, 2004.

N. E. Kay, L. Han, N. Bone, and G. Williams, Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis, Br J Haematol, vol.112, pp.760-767, 2001.

M. J. Keating, S. O'brien, and M. Albitar, Emerging information on the use of rituximab in chronic lymphocytic leukemia, Semin Oncol, vol.29, pp.70-74, 2002.

M. J. Keating, S. O'brien, M. Albitar, S. Lerner, W. Plunkett et al., Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia, J Clin Oncol, vol.23, pp.4079-4088, 2005.

M. J. Keating, S. O'brien, S. Lerner, C. Koller, M. Beran et al., Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy, Blood, vol.92, pp.1165-1171, 1998.

M. Kerkmann, S. Rothenfusser, V. Hornung, A. Towarowski, M. Wagner et al., Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells, J Immunol, vol.170, pp.4465-4474, 2003.

J. A. Khan, E. K. Brint, L. A. O'neill, and L. Tong, Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL, J Biol Chem, vol.279, pp.31664-31670, 2004.

I. F. Khouri, M. Keating, M. Korbling, D. Przepiorka, P. Anderlini et al., Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies, J Clin Oncol, vol.16, pp.2817-2824, 1998.

I. F. Khouri, R. M. Saliba, S. A. Giralt, M. S. Lee, G. J. Okoroji et al.,

M. L. Donato, F. F. Cabanillas, and R. E. Champlin, Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality, Blood, vol.98, pp.3595-3599, 2001.

T. J. Kipps, The CD5 B cell, Adv Immunol, vol.47, pp.117-185, 1989.

D. M. Klinman, D. Currie, I. Gursel, and D. Verthelyi, Use of CpG oligodeoxynucleotides as immune adjuvants, Immunol Rev, vol.199, pp.201-216, 2004.

H. J. Kolb, A. Schattenberg, J. M. Goldman, B. Hertenstein, N. Jacobsen et al.,

J. Mittermueller, T. De-witte, E. Holler, and H. Ansari, Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients, Blood, vol.86, pp.2041-2050, 1995.

W. Kolch, G. Heidecker, G. Kochs, R. Hummel, H. Vahidi et al., Protein kinase C alpha activates RAF-1 by direct phosphorylation, Nature, vol.364, pp.249-252, 1993.

E. Kopp, R. Medzhitov, J. Carothers, C. Xiao, I. Douglas et al., ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway, Genes Dev, vol.13, pp.2059-2071, 1999.

T. Korn, E. Bettelli, W. Gao, A. Awasthi, A. Jager et al.,

K. , IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells, p.239, 2007.

, Nature, vol.448, pp.484-487

A. M. Krieg, CpG motifs in bacterial DNA and their immune effects, Annu Rev Immunol, vol.20, pp.709-760, 2002.

A. M. Krieg, Therapeutic potential of Toll-like receptor 9 activation, Nat Rev Drug Discov, vol.5, pp.471-484, 2006.

A. M. Krieg and A. K. Yi, Rescue of B cells from apoptosis by immune stimulatory CpG DNA, Springer Semin Immunopathol, vol.22, pp.55-61, 2000.

A. Krober, T. Seiler, A. Benner, L. Bullinger, E. Bruckle et al., V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia, Blood, vol.100, pp.1410-1416, 2002.

A. Krug, A. R. French, W. Barchet, J. A. Fischer, A. Dzionek et al., TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function, Immunity, vol.21, pp.107-119, 2004.

E. A. Kurt-jones, M. Chan, S. Zhou, J. Wang, G. Reed et al., Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis, Proc Natl Acad Sci U S A, vol.101, pp.1315-1320, 2004.

E. A. Kurt-jones, L. Popova, L. Kwinn, L. M. Haynes, L. P. Jones et al., Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus, Nat Immunol, vol.1, pp.398-401, 2000.

J. M. Kyriakis and J. Avruch, Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation, Physiol Rev, vol.81, pp.807-869, 2001.

J. Laine, G. Kunstle, T. Obata, M. Sha, and M. Noguchi, The protooncogene TCL1 is an Akt kinase coactivator, Mol Cell, vol.6, pp.395-407, 2000.
DOI : 10.1016/s1097-2765(00)00039-3

URL : https://doi.org/10.1016/s1097-2765(00)00039-3

E. Latz, A. Schoenemeyer, A. Visintin, K. A. Fitzgerald, B. G. Monks et al., TLR9 signals after translocating from the ER to CpG DNA in the lysosome, Nat Immunol, vol.5, pp.190-198, 2004.

E. Latz, A. Visintin, E. Lien, K. A. Fitzgerald, B. G. Monks et al., Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction, J Biol Chem, vol.277, pp.47834-47843, 2002.

J. N. Lavoie, G. L'allemain, A. Brunet, R. Muller, and J. Pouyssegur, Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway, J Biol Chem, vol.271, pp.20608-20616, 1996.

H. H. Lee, H. Dadgostar, Q. Cheng, J. Shu, and G. Cheng, NF-kappaB-mediated upregulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes, Proc Natl Acad Sci U S A, vol.96, pp.9136-9141, 1999.

O. Lees and M. C. Bene, Clusters de différenciation humains, Applications à la caractérisation des hémopathies, 1998.

M. D. Lehner, S. Morath, K. S. Michelsen, R. R. Schumann, and T. Hartung, Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators, J Immunol, vol.166, pp.5161-5167, 2001.

B. Lemaitre, E. Nicolas, L. Michaut, J. M. Reichhart, and J. A. Hoffmann, The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults, Cell, vol.86, pp.973-983, 1996.

M. Leporrier, S. Chevret, B. Cazin, N. Boudjerra, P. Feugier et al., Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients, Blood, vol.98, pp.2319-2325, 2001.

C. Li, J. Zienkiewicz, and J. Hawiger, Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway, J Biol Chem, vol.280, pp.26152-26159, 2005.

S. Li, A. Strelow, E. J. Fontana, and H. Wesche, IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase, Proc Natl Acad Sci U S A, vol.99, pp.5567-5572, 2002.

W. Li, J. Zhang, L. Flechner, T. Hyun, A. Yam et al., Protein kinase C-alpha overexpression stimulates Akt activity and suppresses apoptosis induced by interleukin 3 withdrawal, Oncogene, vol.18, pp.6564-6572, 1999.
DOI : 10.1038/sj.onc.1203065

URL : https://www.nature.com/articles/1203065.pdf

L. E. Sellati, T. J. Yoshimura, A. Flo, T. H. Rawadi, G. Finberg et al., Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products, J Biol Chem, vol.274, pp.33419-33425, 1999.

K. Lin, P. D. Sherrington, M. Dennis, Z. Matrai, J. C. Cawley et al., Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia, Blood, vol.100, pp.1404-1409, 2002.

R. Lin, C. Heylbroeck, P. Genin, P. M. Pitha, and J. Hiscott, Essential role of interferon 241 regulatory factor 3 in direct activation of RANTES chemokine transcription, Mol Cell Biol, vol.19, pp.959-966, 1999.

P. S. Linsley, J. Schelter, J. Burchard, M. Kibukawa, M. M. Martin et al.,

A. L. Jackson, M. Carleton, and L. Lim, Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression, Mol Cell Biol, vol.27, pp.2240-2252, 2007.

E. Liota, K. J. Smith, R. Buckley, P. Menon, and H. Skelton, Imiquimod therapy for molluscum contagiosum, J Cutan Med Surg, vol.4, pp.76-82, 2000.

H. Liu, H. Perlman, L. J. Pagliari, and R. M. Pope, Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation, J Exp Med, vol.194, pp.113-126, 2001.

N. S. Liu and S. O'brien, Monoclonal antibodies in the treatment of chronic lymphocytic leukemia, Med Oncol, vol.21, pp.297-304, 2004.

P. G. Longo, L. Laurenti, S. Gobessi, A. Petlickovski, M. Pelosi et al., The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease, Leukemia, vol.21, pp.110-120, 2007.

M. Lotz, E. Ranheim, and T. J. Kipps, Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells, J Exp Med, vol.179, pp.999-1004, 1994.

G. Lozanski, N. A. Heerema, I. W. Flinn, L. Smith, J. Harbison et al.,

C. , Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions, Blood, vol.103, pp.3278-3281, 2004.

J. Lund, A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki, Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells, J Exp Med, vol.198, pp.513-520, 2003.

J. M. Lund, L. Alexopoulou, A. Sato, M. Karow, N. C. Adams et al., Recognition of single-stranded RNA viruses by Toll-like receptor, 2004.

, Proc Natl Acad Sci U S A, vol.101, pp.5598-5603

J. Lundin, A. Porwit-macdonald, E. D. Rossmann, C. Karlsson, P. Edman et al., Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, p.1, 2004.

, treatment as first-line therapy for B-cell chronic lymphocytic leukaemia, Leukemia, vol.18, p.242

C. Luo and L. Zheng, Independent evolution of Toll and related genes in insects and mammals, Immunogenetics, vol.51, pp.92-98, 2000.

F. Malavasi and E. Ferrero, reviewer: Lee H.C.) Protein Reviews on the Web. The guide on CD38

N. L. Malinin, M. P. Boldin, A. V. Kovalenko, and D. Wallach, MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1, Nature, vol.385, pp.540-544, 1997.

K. Maloum, F. Davi, H. Merle-beral, O. Pritsch, C. Magnac et al., Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia, Blood, vol.96, pp.377-379, 2000.

A. Mansson, M. Adner, U. Hockerfelt, and L. O. Cardell, A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG2006 stimulation, Immunology, vol.118, pp.539-548, 2006.

D. Maraninchi, E. Gluckman, D. Blaise, D. Guyotat, B. Rio et al., Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias, Lancet, vol.2, pp.175-178, 1987.

P. Massari, P. Henneke, Y. Ho, E. Latz, D. T. Golenbock et al., Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent, J Immunol, vol.168, pp.1533-1537, 2002.
DOI : 10.4049/jimmunol.168.4.1533

URL : http://www.jimmunol.org/content/168/4/1533.full.pdf

M. Matsumoto, K. Funami, M. Tanabe, H. Oshiumi, M. Shingai et al., Subcellular localization of Toll-like receptor 3 in human dendritic cells, J Immunol, vol.171, pp.3154-3162, 2003.

M. Matsumoto, S. Kikkawa, M. Kohase, K. Miyake, and T. Seya, Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling, Biochem Biophys Res Commun, vol.293, pp.1364-1369, 2002.

H. Matsushime, D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr et al., , 1994.

, D-type cyclin-dependent kinase activity in mammalian cells, Mol Cell Biol, vol.14, pp.2066-2076

A. Matsuzawa, K. Saegusa, T. Noguchi, C. Sadamitsu, H. Nishitoh et al., ROS-dependent activation of the TRAF6ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity, Nat Immunol, vol.6, pp.587-592, 2005.

J. Mattes, M. Hulett, W. Xie, S. Hogan, M. E. Rothenberg et al., Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process, J Exp Med, vol.197, pp.387-393, 2003.

E. Matutes, K. Owusu-ankomah, R. Morilla, G. Marco, J. Houlihan et al., The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL, Leukemia, vol.8, pp.1640-1645, 1994.

P. Matzinger, The danger model: a renewed sense of self, Science, vol.296, pp.301-305, 2002.

U. Maurer, C. Charvet, A. S. Wagman, E. Dejardin, and D. R. Green, Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1, Mol Cell, vol.21, pp.749-760, 2006.

K. F. Mccarron, J. P. Hammel, and E. D. Hsi, Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders, Am J Clin Pathol, vol.113, pp.805-813, 2000.

M. G. Mcheyzer-williams, B cells as effectors, Curr Opin Immunol, vol.15, pp.354-361, 2003.

P. A. Mcsweeney, D. Niederwieser, J. A. Shizuru, B. M. Sandmaier, A. J. Molina et al.,

J. L. Wagner, S. Minor, F. R. Appelbaum, W. I. Bensinger, E. Bryant et al.,

E. Georges, G. E. Grumet, F. C. Kiem, H. P. Torok-storb, B. Yu et al., Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versustumor effects, Blood, vol.97, pp.3390-3400, 2001.

S. M. Mcwhirter, K. A. Fitzgerald, J. Rosains, D. C. Rowe, D. T. Golenbock et al., IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts, Proc Natl Acad Sci U S A, vol.101, pp.233-238, 2004.

T. K. Means, S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock et al., Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis, J Immunol, vol.163, pp.3920-3927, 1999.

R. Medzhitov, C. A. Janeway, and . Jr, Decoding the patterns of self and nonself by the innate immune system, Science, vol.296, pp.298-300, 2002.

R. Medzhitov, P. Preston-hurlburt, C. A. Janeway, and . Jr, A human homologue of the Drosophila Toll protein signals activation of adaptive immunity, Nature, vol.388, pp.394-397, 1997.

R. Medzhitov, P. Preston-hurlburt, E. Kopp, A. Stadlen, C. Chen et al., MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways, Mol Cell, vol.2, pp.253-258, 1998.
DOI : 10.1016/s1097-2765(00)80136-7

URL : https://doi.org/10.1016/s1097-2765(00)80136-7

J. Melchjorsen, S. B. Jensen, L. Malmgaard, S. B. Rasmussen, F. Weber et al., Activation of Innate Defense against a Paramyxovirus Is Mediated by RIG-I and TLR7 and TLR8 in a Cell-Type-Specific Manner, J Virol, vol.79, pp.12944-12951, 2005.

B. T. Messmer, D. Messmer, S. L. Allen, J. E. Kolitz, P. Kudalkar et al.,

M. K. Hellerstein and N. Chiorazzi, In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells, J Clin Invest, vol.115, pp.755-764, 2005.

T. Meyer, I. Nindl, T. Schmook, C. Ulrich, W. Sterry et al., Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures, Br J Dermatol, vol.149, pp.9-14, 2003.

E. Meylan, K. Burns, K. Hofmann, V. Blancheteau, F. Martinon et al., RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation, Nat Immunol, vol.5, pp.503-507, 2004.
DOI : 10.1038/ni1061

A. S. Michallet, F. Nicolini, and M. Michallet, Alloreactive donor lymphocytes (DLI) after allogeneic hematopoietic stem cell transplantation (HSCT): study of toxicity and efficacy, 2003.

, Bull Cancer, vol.90, pp.758-762

M. Michallet, N. Dhedin, and A. S. Michallet, Allogeneic hematopoietic stem-cell transplantation for hematological malignancies, Bull Cancer, vol.88, pp.908-926, 2001.

I. Miconnet, S. Koenig, D. Speiser, A. Krieg, P. Guillaume et al., CpG are efficient adjuvants for specific CTL induction against tumor antigenderived peptide, J Immunol, vol.168, pp.1212-1218, 2002.
DOI : 10.4049/jimmunol.168.3.1212

URL : http://www.jimmunol.org/content/168/3/1212.full.pdf

R. L. Miller, J. F. Gerster, M. L. Owens, H. B. Slade, and M. A. Tomai, Imiquimod applied topically: a novel immune response modifier and new class of drug, Int J Immunopharmacol, vol.21, pp.1-14, 1999.

M. Mohty, D. Isnardon, A. Charbonnier, M. Lafage-pochitaloff, M. Merlin et al., Generation of potent T(h)1 responses from patients with lymphoid malignancies after differentiation of B lymphocytes into dendritic-like cells, Int Immunol, vol.14, pp.741-750, 2002.

R. F. Murphy, Flow Cytometry and Sorting Part, vol.1, 1996.

S. Molica, D. Levato, N. Cascavilla, L. Levato, and P. Musto, Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta2microglobulin in B-cell chronic lymphocytic leukemia, Eur J Haematol, vol.62, pp.117-122, 1999.

S. Molica, G. Vitelli, D. Levato, L. Levato, A. Dattilo et al., Clinicobiological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia, Haematologica, vol.84, pp.208-211, 1999.

J. J. Mond, N. Feuerstein, C. H. June, A. K. Balapure, R. I. Glazer et al., Bimodal effect of phorbol ester on B cell activation. Implication for the role of protein kinase C, J Biol Chem, vol.266, pp.4458-4463, 1991.

M. M. Monick, A. B. Carter, D. M. Flaherty, M. W. Peterson, and G. W. Hunninghake, Protein kinase C zeta plays a central role in activation of the p42/44 mitogen-activated protein kinase by endotoxin in alveolar macrophages, J Immunol, vol.165, pp.4632-4639, 2000.

M. Montillo, T. Hamblin, M. Hallek, E. Montserrat, and E. Morra, Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies, Haematologica, vol.90, pp.391-399, 2005.

E. Montserrat and C. Rozman, Chronic lymphocytic leukemia: present status, Ann Oncol, vol.6, pp.219-235, 1995.

E. Montserrat, J. Sanchez-bisono, N. Vinolas, and C. Rozman, Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance, Br J Haematol, vol.62, pp.567-575, 1986.

K. W. Moore, R. De-waal-malefyt, R. L. Coffman, and A. O'garra, Interleukin-10 and the interleukin-10 receptor, Annu Rev Immunol, vol.19, pp.683-765, 2001.

F. Morabito, M. Filangeri, I. Callea, G. Sculli, V. Callea et al., Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs, Haematologica, vol.82, pp.16-20, 1997.

P. Moreton and P. Hillmen, Alemtuzumab therapy in B-cell lymphoproliferative disorders, Semin Oncol, vol.30, pp.493-501, 2003.
DOI : 10.1016/s0093-7754(03)00253-7

E. Morgan, R. Varro, H. Sepulveda, J. A. Ember, J. Apgar et al., Cytometric bead array: a multiplexed assay platform with applications in various areas of biology, Clin Immunol, vol.110, pp.252-266, 2004.

E. Morris, K. Thomson, C. Craddock, P. Mahendra, D. Milligan et al., Outcomes after alemtuzumab-containing reducedintensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma, Blood, vol.104, pp.3865-3871, 2004.
DOI : 10.1182/blood-2004-03-1105

URL : http://www.bloodjournal.org/content/104/13/3865.full.pdf

O. Moshynska, K. Sankaran, P. Pahwa, and A. Saxena, , 2004.

, Natl Cancer Inst, vol.96, pp.673-682

T. R. Mosmann and R. L. Coffman, TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties, Annu Rev Immunol, vol.7, pp.145-173, 1989.

P. N. Moynagh, TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway, Trends Immunol, vol.26, pp.469-476, 2005.

M. Muzio, D. Bosisio, N. Polentarutti, G. D'amico, A. Stoppacciaro et al., Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells, J Immunol, vol.164, pp.5998-6004, 2000.

M. Muzio, N. Polentarutti, D. Bosisio, M. Kumar, P. P. Mantovani et al., Toll-like receptor family and signalling pathway, Biochem Soc Trans, vol.28, pp.563-566, 2000.

M. Nagasaki, S. Morikawa, I. Torii, J. Zhang, and K. Morikawa, A human B-lineage dendritic cell line, HBM-noda and its potential role in human T-cell leukemia/lymphoma virus type I infection, Pathol Int, vol.50, pp.280-290, 2000.
DOI : 10.1046/j.1440-1827.2000.01040.x

T. Nakaya, M. Sato, N. Hata, M. Asagiri, H. Suemori et al., Gene induction pathways mediated by distinct IRFs during viral infection, 2001.
DOI : 10.1006/bbrc.2001.4913

, Biochem Biophys Res Commun, vol.283, pp.1150-1156

D. T. Nguyen, J. A. Amess, H. Doughty, L. Hendry, and L. W. Diamond, IDEC-C2B8 anti-CD20 (rituximab) immunotherapy in patients with low-grade non-Hodgkin's lymphoma and lymphoproliferative disorders: evaluation of response on 48 patients, Eur J Haematol, vol.62, pp.76-82, 1999.

H. Nguyen, D. M. Gitig, and A. Koff, Cell-free degradation of p27(kip1), a G1 cyclindependent kinase inhibitor, is dependent on CDK2 activity and the proteasome, Mol Cell Biol, vol.19, pp.1190-1201, 1999.

J. A. Nilsson and J. L. Cleveland, Myc pathways provoking cell suicide and cancer, Oncogene, vol.22, pp.9007-9021, 2003.
DOI : 10.1038/sj.onc.1207261

URL : https://www.nature.com/articles/1207261.pdf

T. Nishiya and A. L. Defranco, Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors, J Biol Chem, vol.279, pp.19008-19017, 2004.

T. Nishiya, E. Kajita, S. Miwa, and A. L. Defranco, TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements, J Biol Chem, vol.280, pp.37107-37117, 2005.
DOI : 10.1074/jbc.m504951200

S. O'brien, A. Del-giglio, and M. Keating, Advances in the biology and treatment of Bcell chronic lymphocytic leukemia, Blood, vol.85, pp.307-318, 1995.

S. M. O'brien, H. M. Kantarjian, D. A. Thomas, J. Cortes, F. J. Giles et al., Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia, Cancer, vol.98, pp.2657-2663, 2003.

G. Oganesyan, S. K. Saha, B. Guo, J. Q. He, A. Shahangian et al., Critical role of TRAF3 in the Toll-like receptor-dependent andindependent antiviral response, Nature, vol.439, pp.208-211, 2006.

K. Ohashi, V. Burkart, S. Flohe, and H. Kolb, Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex, J Immunol, vol.164, pp.558-561, 2000.

Y. Okamura, M. Watari, E. S. Jerud, D. W. Young, S. T. Ishizaka et al., The extra domain A of fibronectin activates Toll-like receptor 4, J Biol Chem, vol.3, pp.10229-10233, 2001.

L. A. O'neill, K. A. Fitzgerald, and A. G. Bowie, The Toll-IL-1 receptor adaptor family grows to five members, Trends Immunol, vol.24, pp.286-290, 2003.

J. A. Orchard, R. E. Ibbotson, Z. Davis, A. Wiestner, A. Rosenwald et al., ZAP-70 expression and prognosis in chronic lymphocytic leukaemia, Lancet, vol.363, pp.105-111, 2004.

M. Osaki, S. Kase, K. Adachi, A. Takeda, K. Hashimoto et al., Inhibition of the PI3K-Akt signaling pathway enhances the sensitivity of Fas-mediated apoptosis in human gastric carcinoma cell line, MKN-45, J Cancer Res Clin Oncol, vol.130, pp.8-14, 2004.

M. Osaki, M. Oshimura, and H. Ito, PI3K-Akt pathway: its functions and alterations in human cancer, Apoptosis, vol.9, pp.667-676, 2004.

D. Oscier, C. Fegan, P. Hillmen, T. Illidge, S. Johnson et al., Guidelines on the diagnosis and management of chronic lymphocytic leukaemia, Br J Haematol, vol.125, pp.294-317, 2004.

D. G. Oscier, A. C. Gardiner, S. J. Mould, S. Glide, Z. A. Davis et al.,

T. J. Hamblin, Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors, Blood, vol.100, pp.1177-1184, 2002.

D. G. Oscier, A. Thompsett, D. Zhu, and F. K. Stevenson, Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities, Blood, vol.89, pp.4153-4160, 1997.

A. Osterborg, A. Werner, E. Halapi, J. Lundin, U. Harmenberg et al., Clonal CD8+ and CD52-T cells are induced in responding B cell lymphoma patients treated with Campath-1H (anti-CD52), Eur J Haematol, vol.58, pp.5-13, 1997.

A. Ozinsky, D. M. Underhill, J. D. Fontenot, A. M. Hajjar, K. D. Smith et al., The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors, Proc Natl Acad Sci U S A, vol.97, pp.13766-13771, 2000.

C. R. Parish, Fluorescent dyes for lymphocyte migration and proliferation studies, Immunol Cell Biol, vol.77, pp.499-508, 1999.

J. S. Park, D. Svetkauskaite, Q. He, J. Y. Kim, D. Strassheim et al., Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein, J Biol Chem, vol.279, pp.7370-7377, 2004.

Y. Pekarsky, A. Koval, C. Hallas, R. Bichi, M. Tresini et al., Tcl1 enhances Akt kinase activity and mediates its nuclear translocation, Proc Natl Acad Sci U S A, vol.97, pp.3028-3033, 2000.

Y. Pekarsky, U. Santanam, A. Cimmino, A. Palamarchuk, A. Efanov et al.,

C. M. Croce, Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181, Cancer Res, vol.66, pp.11590-11593, 2006.

C. Pepper, T. Hoy, and D. P. Bentley, Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance, Br J Cancer, vol.76, pp.935-938, 1997.

A. K. Perry, E. K. Chow, J. B. Goodnough, W. C. Yeh, and G. Cheng, Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection, J Exp Med, vol.199, pp.1651-1658, 2004.

S. Pillai, A. Cariappa, and S. T. Moran, Marginal zone B cells, Annu Rev Immunol, vol.23, pp.161-196, 2005.

A. Poltorak, X. He, I. Smirnova, M. Y. Liu, C. Van-huffel et al., Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene, Science, vol.282, pp.2085-2088, 1998.

K. R. Rai, B. L. Peterson, F. R. Appelbaum, J. Kolitz, L. Elias et al., Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia, p.249, 2000.

, Engl J Med, vol.343, pp.1750-1757

K. R. Rai and A. Sawitsky, A review of the prognostic role of cytogenetic, phenotypic, morphologic, and immune function characteristics in chronic lymphocytic leukemia, Blood Cells, vol.12, pp.327-338, 1987.

K. R. Rai, A. Sawitsky, E. P. Cronkite, A. D. Chanana, R. N. Levy et al., Clinical staging of chronic lymphocytic leukemia, Blood, vol.46, pp.219-234, 1975.

M. Raisova, A. M. Hossini, J. Eberle, C. Riebeling, T. Wieder et al., The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis, J Invest Dermatol, vol.117, pp.333-340, 2001.

E. A. Ranheim and T. J. Kipps, Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal, J Exp Med, vol.177, pp.925-935, 1993.

E. A. Ranheim and T. J. Kipps, Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L, Cell Immunol, vol.161, pp.226-235, 1995.

J. C. Rassa, J. L. Meyers, Y. Zhang, R. Kudaravalli, and S. R. Ross, Murine retroviruses activate B cells via interaction with toll-like receptor 4, Proc Natl Acad Sci U S A, vol.99, pp.2281-2286, 2002.

L. Z. Rassenti, L. Huynh, T. L. Toy, L. Chen, M. J. Keating et al.,

S. Flinn, I. W. Rai, K. R. Byrd, J. C. Kay, N. E. Greaves et al., ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia, N Engl J Med, vol.351, pp.893-901, 2004.

S. Read and F. Powrie, CD4(+) regulatory T cells, Curr Opin Immunol, vol.13, pp.644-649, 2001.

A. Redaelli, B. L. Laskin, J. M. Stephens, M. F. Botteman, and C. L. Pashos, The clinical and epidemiological burden of chronic lymphocytic leukaemia, Eur J Cancer Care (Engl), vol.13, pp.279-287, 2004.

J. P. Ridge, D. Rosa, F. Matzinger, and P. , A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell, Nature, vol.393, pp.474-478, 1998.

L. A. Ries, D. Melbert, M. Krapcho, A. Mariotto, B. A. Miller et al., Cancer Statistics Review, 1975.

, Disponible sur

I. Ringshausen, F. Schneller, C. Bogner, S. Hipp, J. Duyster et al., Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta, Blood, vol.100, pp.3741-3748, 2002.

L. E. Robertson, W. Plunkett, K. Mcconnell, M. J. Keating, and T. J. Mcdonnell, Bcl2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome, Leukemia, vol.10, pp.456-459, 1996.

S. P. Robinson, A. H. Goldstone, S. Mackinnon, A. Carella, N. Russell et al., Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation, Blood, vol.100, pp.4310-4316, 2002.

F. L. Rock, G. Hardiman, J. C. Timans, R. A. Kastelein, and J. F. Bazan, A family of human receptors structurally related to Drosophila Toll, Proc Natl Acad Sci U S A, vol.95, pp.588-593, 1998.
DOI : 10.1073/pnas.95.2.588

URL : http://www.pnas.org/content/95/2/588.full.pdf

S. A. Rosenberg, J. C. Yang, D. J. Schwartzentruber, P. Hwu, F. M. Marincola et al., Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma, Nat Med, vol.4, pp.321-327, 1998.

E. Rossi, E. Matutes, R. Morilla, K. Owusu-ankomah, A. M. Heffernan et al., Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia, Leukemia, vol.10, pp.494-497, 1996.

G. Rothe and G. Schmitz, Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies, Working Group on Flow Cytometry and Image Analysis. Leukemia, vol.10, pp.877-895, 1996.

C. Rozman and E. Montserrat, Chronic lymphocytic leukemia, N Engl J Med, vol.333, pp.1052-1057, 1995.

P. A. Ruffini, S. S. Neelapu, L. W. Kwak, and A. Biragyn, Idiotypic vaccination for Bcell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines, Haematologica, vol.87, pp.989-1001, 2002.

K. Saegusa, S. Yotsumoto, S. Kato, and Y. Aramaki, Phosphatidylinositol 3-kinasemediated regulation of IL-10 and IL-12 production in macrophages stimulated with CpG oligodeoxynucleotide, Molecular Immunology, vol.44, pp.1323-1330, 2007.

X. Sagaert, D. Wolf-peeters, and C. , Classification of B-cells according to their differentiation status, their micro-anatomical localisation and their developmental lineage, Immunol Lett, vol.90, pp.179-186, 2003.
DOI : 10.1016/j.imlet.2003.09.007

S. Sakaguchi, Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses, Annu Rev Immunol, vol.22, pp.531-562, 2004.

S. Salasche, Imiquimod 5% cream: a new treatment option for basal cell carcinoma, Int J Dermatol, vol.41, pp.16-20, 2002.
DOI : 10.1111/j.1365-4632.2002.00020.x

J. R. Salisbury, N. T. Rapson, J. D. Codd, M. V. Rogers, and A. B. Nethersell, Immunohistochemical analysis of CDw52 antigen expression in non-Hodgkin's lymphomas, J Clin Pathol, vol.47, pp.313-317, 1994.
DOI : 10.1136/jcp.47.4.313

URL : https://jcp.bmj.com/content/jclinpath/47/4/313.full.pdf

M. Sarfati, S. Chevret, C. Chastang, G. Biron, P. Stryckmans et al., Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia, Blood, vol.88, pp.4259-4264, 1996.

S. N. Sarkar, K. L. Peters, C. P. Elco, S. Sakamoto, S. Pal et al., Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling, 2004.

, Nat Struct Mol Biol, vol.11, pp.1060-1067

M. Sasai, H. Oshiumi, M. Matsumoto, N. Inoue, F. Fujita et al., Cutting Edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation, J Immunol, vol.174, pp.27-30, 2005.
DOI : 10.4049/jimmunol.174.1.27

URL : http://www.jimmunol.org/content/jimmunol/174/1/27.full.pdf

M. Schön, A. B. Bong, C. Drewniok, J. Herz, C. C. Geilen et al., Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod, J Natl Cancer Inst, vol.95, pp.1138-1149, 2003.

M. P. Schön and M. Schön, Immune modulation and apoptosis induction: two sides of the antitumoral activity of imiquimod, Apoptosis, vol.9, pp.291-298, 2004.

M. P. Schön, M. Schön, and K. N. Klotz, The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7-and TLR8independent fashion, J Invest Dermatol, vol.126, pp.1338-1347, 2006.

M. P. Schön, B. G. Wienrich, C. Drewniok, A. B. Bong, J. Eberle et al., Death receptor-independent apoptosis in malignant melanoma induced by the small-molecule immune response modifier imiquimod, J Invest Dermatol, vol.122, pp.1266-1276, 2004.

D. C. Schonwasser, R. M. Marais, C. J. Marshall, and P. J. Parker, Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes, Mol Cell Biol, vol.18, pp.790-798, 1998.

J. L. Schultze, S. Michalak, M. J. Seamon, G. Dranoff, K. Jung et al., CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigenspecific T cells for adoptive immunotherapy, J Clin Invest, vol.100, pp.2757-2765, 1997.

R. Schwandner, R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning, , 1999.

, Peptidoglycan-and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2, J Biol Chem, vol.274, pp.17406-17409

E. Schweighoffer, L. Vanes, A. Mathiot, T. Nakamura, and V. L. Tybulewicz, Unexpected requirement for ZAP-70 in pre-B cell development and allelic exclusion, Immunity, vol.18, pp.523-533, 2003.

T. D. Shanafelt, S. M. Geyer, and N. E. Kay, Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL, Blood, vol.103, pp.1202-1210, 2004.

T. D. Shanafelt, T. E. Witzig, S. R. Fink, R. B. Jenkins, S. F. Paternoster et al., Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia, J Clin Oncol, vol.24, pp.4634-4641, 2006.

P. S. Shapiro, E. Vaisberg, A. J. Hunt, N. S. Tolwinski, A. M. Whalen et al., Activation of the MKK/ERK pathway during somatic cell mitosis: direct interactions of active ERK with kinetochores and regulation of the mitotic 3F3/2 phosphoantigen, J Cell Biol, vol.142, pp.1533-1545, 1998.

N. A. Sharkey and P. M. Blumberg, Comparison of the activity of phorbol 12-myristate 13-acetate and the diglyceride glycerol 1-myristate 2-acetate, Carcinogenesis, vol.7, pp.677-679, 1986.

S. Sharma, B. R. Tenoever, N. Grandvaux, G. P. Zhou, R. Lin et al., Triggering the interferon antiviral response through an IKK-related pathway, Science, vol.300, pp.1148-1151, 2003.

H. Shibuya, K. Yamaguchi, K. Shirakabe, A. Tonegawa, Y. Gotoh et al., TAB1: an activator of the TAK1 MAPKKK in TGFbeta signal transduction, Science, vol.272, pp.1179-1182, 1996.

S. Shumack, J. Robinson, S. Kossard, L. Golitz, H. Greenway et al., Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens, Arch Dermatol, vol.138, pp.1165-1171, 2002.

C. Shustik, R. Mick, R. Silver, A. Sawitsky, K. Rai et al., Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observation, Hematol Oncol, vol.6, pp.7-12, 1988.

R. Sidbury, N. Neuschler, E. Neuschler, P. Sun, X. Q. Wang et al., Topically applied imiquimod inhibits vascular tumor growth in vivo, J Invest Dermatol, vol.121, pp.1205-1209, 2003.

J. L. Slack, K. Schooley, T. P. Bonnert, J. L. Mitcham, E. E. Qwarnstrom et al.,

S. K. Dower, Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways, J Biol Chem, vol.275, pp.4670-4678, 2000.

S. Slavin, R. Or, M. Aker, M. Y. Shapira, S. Panigrahi et al., Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: past accomplishments and future goals, Cancer Chemother Pharmacol, vol.48, pp.79-84, 2001.

S. T. Smiley, J. A. King, and W. W. Hancock, Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4, J Immunol, vol.167, pp.2887-2894, 2001.

M. F. Smith, . Jr, A. Mitchell, G. Li, S. Ding et al., Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells, J Biol Chem, vol.278, pp.32552-32560, 2003.

J. Song, S. Salek-ardakani, P. R. Rogers, M. Cheng, L. Van-parijs et al., The costimulation-regulated duration of PKB activation controls T cell longevity, Nat Immunol, vol.5, pp.150-158, 2004.

O. Sozeri, K. Vollmer, M. Liyanage, D. Frith, G. Kour et al., Activation of the c-Raf protein kinase by protein kinase C phosphorylation, Oncogene, vol.7, pp.2259-2262, 1992.

D. E. Spaner, R. L. Miller, J. Mena, L. Grossman, V. Sorrenti et al., Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the Toll-like receptor-7/8 agonist, imiquimod, Leuk Lymphoma, vol.46, pp.935-939, 2005.

D. E. Spaner, Y. Shi, D. White, J. Mena, C. Hammond et al., Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells, Leukemia, vol.20, pp.286-295, 2006.

A. Stephanou and D. S. Latchman, Opposing actions of STAT-1 and STAT-3, Growth Factors, vol.23, pp.177-182, 2005.

E. Stockfleth, T. Meyer, B. Benninghoff, S. Salasche, L. Papadopoulos et al., A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses, Arch Dermatol, vol.138, pp.1498-1502, 2002.

B. Stockinger and M. Veldhoen, Differentiation and function of Th17 T cells, Curr Opin Immunol, vol.19, pp.281-286, 2007.

G. W. Sullivan and J. Linden, Role of A2A adenosine receptors in inflammation, Drug Development Research, vol.45, pp.103-112, 1998.

T. P. Sullivan, T. Dearaujo, V. Vincek, and B. Berman, Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream or vehicle for apoptosis and lymphocyte phenotyping, Dermatol Surg, vol.29, pp.1181-1186, 2003.

X. M. Sun, M. Macfarlane, J. Zhuang, B. B. Wolf, D. R. Green et al., Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis, J Biol Chem, vol.274, pp.5053-5060, 1999.

H. Suzuki, S. Matsuda, Y. Terauchi, M. Fujiwara, T. Ohteki et al., PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction, Nat Immunol, vol.4, pp.280-286, 2003.

N. Suzuki, S. Suzuki, G. S. Duncan, D. G. Millar, T. Wada et al.,

W. Yeh, Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4, Nature, vol.416, pp.750-756, 2002.

N. Suzuki, S. Suzuki, and W. C. Yeh, IRAK-4 as the central TIR signaling mediator in innate immunity, Trends Immunol, vol.23, pp.503-506, 2002.

K. Tabeta, P. Georgel, E. Janssen, X. Du, K. Hoebe et al., Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection, Proc Natl Acad Sci U S A, vol.101, pp.3516-3521, 2004.

G. Takaesu, S. Kishida, A. Hiyama, K. Yamaguchi, H. Shibuya et al., , vol.2, p.1, 2000.

, MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway, Mol Cell, vol.5, pp.649-658

A. Takaoka, H. Yanai, S. Kondo, G. Duncan, H. Negishi et al., Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors, Nature, vol.434, pp.243-249, 2005.

K. Takeda, T. Kaisho, and S. Akira, TOLL-LIKE RECEPTORS, Annual Review of Immunology, vol.21, pp.335-376, 2003.

O. Takeuchi and S. Akira, Toll-like receptors; their physiological role and signal transduction system, Int Immunopharmacol, vol.1, pp.625-635, 2001.

O. Takeuchi, T. Kawai, H. Sanjo, N. G. Copeland, D. J. Gilbert et al., TLR6: A novel member of an expanding toll-like receptor family, Gene, vol.231, pp.59-65, 1999.
DOI : 10.1016/s0378-1119(99)00098-0

O. Takeuchi, S. Sato, T. Horiuchi, K. Hoshino, K. Takeda et al., Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins, J Immunol, vol.169, pp.10-14, 2002.

T. Taniguchi and A. Takaoka, The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors, 2002.

, Curr Opin Immunol, vol.14, pp.111-116

D. D. Taub, M. Anver, J. J. Oppenheim, D. L. Longo, and W. J. Murphy, T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo, J Clin Invest, vol.97, pp.1931-1941, 1996.
DOI : 10.1172/jci118625

URL : http://www.jci.org/articles/view/118625/files/pdf

C. Termeer, F. Benedix, J. Sleeman, C. Fieber, U. Voith et al., Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4, J Exp Med, vol.195, pp.99-111, 2002.
DOI : 10.1084/jem.20001858

URL : http://jem.rupress.org/content/195/1/99.full.pdf

W. D. Thomas and P. Hersey, TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells, J Immunol, vol.161, pp.2195-2200, 1998.

M. A. Tomai, L. M. Imbertson, T. L. Stanczak, L. T. Tygrett, and T. J. Waldschmidt, The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes, Cell Immunol, vol.203, pp.55-65, 2000.
DOI : 10.1006/cimm.2000.1673

K. Triantafilou, G. Orthopoulos, E. Vakakis, M. A. Ahmed, D. T. Golenbock et al.,

M. Triantafilou and M. , Human cardiac inflammatory responses triggered by, 2005.

, Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent, Cell Microbiol, vol.7, pp.1117-1126

A. Trojan, J. L. Schultze, M. Witzens, R. H. Vonderheide, M. Ladetto et al., Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies, Nat Med, vol.6, pp.667-672, 2000.
DOI : 10.1038/76243

M. F. Tsan and B. Gao, Endogenous ligands of Toll-like receptors, J Leukoc Biol, vol.76, pp.514-519, 2004.

S. Uddin, A. R. Hussain, A. K. Siraj, P. S. Manogaran, N. A. Al-jomah et al., Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival, Blood, vol.108, pp.4178-4186, 2006.

Y. Ueda, S. Hirai, S. Osada, A. Suzuki, K. Mizuno et al., Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf, 1996.

, J Biol Chem, vol.271, pp.23512-23519

R. J. Ulevitch and P. S. Tobias, Recognition of gram-negative bacteria and endotoxin by the innate immune system, Curr Opin Immunol, vol.11, pp.19-22, 1999.

D. M. Underhill, A. Ozinsky, K. D. Smith, and A. Aderem, Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages, Proc Natl Acad Sci U S A, vol.96, pp.14459-14463, 1999.
DOI : 10.1073/pnas.96.25.14459

URL : https://www.pnas.org/content/pnas/96/25/14459.full.pdf

R. M. Vabulas, P. Ahmad-nejad, C. Da-costa, T. Miethke, C. J. Kirschning et al., Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells, J Biol Chem, vol.276, pp.31332-31339, 2001.

R. M. Vabulas, P. Ahmad-nejad, S. Ghose, C. J. Kirschning, R. D. Issels et al., HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway, J Biol Chem, vol.277, pp.15107-15112, 2002.

R. M. Vabulas, S. Braedel, N. Hilf, H. Singh-jasuja, S. Herter et al., The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway, J Biol Chem, vol.277, pp.20847-20853, 2002.
DOI : 10.1074/jbc.m200425200

URL : http://www.jbc.org/content/277/23/20847.full.pdf

M. A. Valencia-sanchez, J. Liu, G. J. Hannon, and R. Parker, Control of translation and mRNA degradation by miRNAs and siRNAs, Genes Dev, vol.20, pp.515-524, 2006.
DOI : 10.1101/gad.1399806

URL : http://genesdev.cshlp.org/content/20/5/515.full.pdf

L. E. Van-den-hove, S. W. Van-gool, P. Vandenberghe, M. Bakkus, K. Thielemans et al., CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules, Leukemia, vol.11, pp.572-580, 1997.

D. Van-duin, R. Medzhitov, and A. C. Shaw, Triggering TLR signaling in vaccination, Trends in Immunology, vol.27, pp.49-55, 2006.

F. M. Vessiere-louveaux, W. Hijmans, and H. R. Schuit, Presence of multiple isotypes on the surface of human tonsillar lymphocytes, Eur J Immunol, vol.10, pp.186-191, 1980.

M. Viau and M. Zouali, B-lymphocytes, innate immunity, and autoimmunity, Clin Immunol, vol.114, pp.17-26, 2005.
DOI : 10.1016/j.clim.2004.08.019

D. Vidal, X. Matias-guiu, and A. Alomar, Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis, Br J Dermatol, vol.151, pp.656-662, 2004.

V. Krogh and G. , Management of anogenital warts (condylomata acuminata), Eur J Dermatol, vol.11, pp.598-603, 2001.

V. Krogh, G. Lacey, C. J. Gross, G. Barrasso, R. Schneider et al., European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts, Sex Transm Infect, vol.76, pp.162-168, 2000.

R. Vrhovac, A. Delmer, R. Tang, J. P. Marie, R. Zittoun et al., Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia, Blood, vol.91, pp.4694-4700, 1998.

F. Vuillier, K. Maloum, E. K. Thomas, C. Magnac, G. Dumas et al., Idiotype-pulsed dendritic cells are able to induce antitumoral cytotoxic CD8 cells in chronic lymphocytic leukaemia, Br J Haematol, vol.120, pp.243-250, 2003.
DOI : 10.1046/j.1365-2141.2003.04075.x

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2141.2003.04075.x

H. Wagner, Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity, Curr Opin Microbiol, vol.5, pp.62-69, 2002.
DOI : 10.1016/s1369-5274(02)00287-4

M. Wagner, H. Poeck, B. Jahrsdoerfer, S. Rothenfusser, D. Prell et al., IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA, J Immunol, vol.172, pp.954-963, 2004.
DOI : 10.4049/jimmunol.172.2.954

URL : http://www.jimmunol.org/content/172/2/954.full.pdf

C. Wang, L. Deng, M. Hong, G. R. Akkaraju, J. Inoue et al., TAK1 is a ubiquitin-dependent kinase of MKK and IKK, Nature, vol.412, pp.346-351, 2001.
DOI : 10.1038/35085597

Z. Wang, J. G. Karras, T. P. Colarusso, L. C. Foote, and T. L. Rothstein, Unmethylated CpG motifs protect murine B lymphocytes against Fas-mediated apoptosis, Cell Immunol, vol.180, pp.162-167, 1997.
DOI : 10.1006/cimm.1997.1156

G. J. Weiner, The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides, J Leukoc Biol, vol.68, pp.455-463, 2000.

C. Werts, R. I. Tapping, J. C. Mathison, T. H. Chuang, V. Kravchenko et al., Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism, Nat Immunol, vol.2, pp.346-352, 2001.
DOI : 10.1038/86354

R. D. Whelan and P. J. Parker, Loss of protein kinase C function induces an apoptotic response, Oncogene, vol.16, pp.1939-1944, 1998.
DOI : 10.1038/sj.onc.1201725

URL : https://www.nature.com/articles/1201725.pdf

A. Wiestner, A. Rosenwald, T. S. Barry, G. Wright, R. E. Davis et al.,

D. C. Arthur, G. E. Marti, W. H. Wilson, T. J. Hamblin, D. G. Oscier et al., ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile, Blood, vol.101, pp.4944-4951, 2003.

C. Wietek, S. M. Miggin, C. A. Jefferies, and L. A. O'neill, Interferon regulatory factor3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-kappa, J Biol Chem, vol.278, pp.50923-50931, 2003.

M. G. Wing, T. Moreau, J. Greenwood, R. M. Smith, G. Hale et al., Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18, 1996.

, LFA-1) on NK cells, J Clin Invest, vol.98, pp.2819-2826

D. H. Wyllie, E. Kiss-toth, A. Visintin, S. C. Smith, S. Boussouf et al.,

S. K. Dower, Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses, J Immunol, vol.165, pp.7125-7132, 2000.

M. Q. Xia, G. Hale, and H. Waldmann, Efficient complement-mediated lysis of cells containing the CAMPATH-1 (CDw52) antigen, Mol Immunol, vol.30, pp.1089-1096, 1993.

Y. Xu, X. Tao, B. Shen, T. Horng, R. Medzhitov et al., Structural basis for signal transduction by the Toll/interleukin-1 receptor domains, Nature, vol.408, pp.111-115, 2000.
DOI : 10.1038/35040600

K. Yamaguchi, K. Shirakabe, H. Shibuya, K. Irie, I. Oishi et al., Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction, Science, vol.270, 1995.

M. Yamamoto, S. Sato, H. Hemmi, K. Hoshino, T. Kaisho et al., , 2003.

, MyD88-independent toll-like receptor signaling pathway, Science, vol.301, pp.640-643

M. Yamamoto, S. Sato, H. Hemmi, H. Sanjo, S. Uematsu et al., Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4, Nature, vol.420, pp.324-329, 2002.

M. Yamamoto, S. Sato, H. Hemmi, S. Uematsu, K. Hoshino et al., TRAM is specifically involved in the Toll-like receptor 4mediated MyD88-independent signaling pathway, Nat Immunol, vol.4, pp.1144-1150, 2003.
DOI : 10.1038/ni986

E. T. Yanagihara, R. K. Blaisdell, T. Hayashi, and R. J. Lukes, Malignant lymphoma in Hawaii-Japanese: a retrospective morphologic survey, Hematol Oncol, vol.7, pp.219-232, 1989.
DOI : 10.1002/hon.2900070305

G. Yap, M. Pesin, and A. Sher, Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii, J Immunol, vol.165, pp.628-631, 2000.

K. Yasuda, P. Yu, C. J. Kirschning, B. Schlatter, F. Schmitz et al., Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and-independent pathways, J Immunol, vol.174, pp.6129-6136, 2005.
DOI : 10.4049/jimmunol.174.10.6129

URL : http://www.jimmunol.org/content/174/10/6129.full.pdf

M. Yasukawa, T. Shiroguchi, A. Inatsuki, and Y. Kobayashi, Antigen presentation in an HLA-DR-restricted fashion by B-cell chronic lymphocytic leukemia cells, Blood, vol.72, pp.102-108, 1988.

M. J. Yellin, J. Sinning, L. R. Covey, W. Sherman, J. J. Lee et al., T lymphocyte T cell-B cellactivating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity, J Immunol, vol.153, pp.666-674, 1994.

A. K. Yi, M. Chang, D. W. Peckham, A. M. Krieg, and R. F. Ashman, CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry, J Immunol, vol.160, pp.5898-5906, 1998.

A. K. Yi, P. Hornbeck, D. E. Lafrenz, and A. M. Krieg, CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL, J Immunol, vol.157, pp.4918-4925, 1996.

A. K. Yi, D. W. Peckham, R. F. Ashman, and A. M. Krieg, CpG DNA rescues B cells from apoptosis by activating NFkappaB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway, Int Immunol, vol.11, pp.2015-2024, 1999.
DOI : 10.1093/intimm/11.12.2015

URL : https://academic.oup.com/intimm/article-pdf/11/12/2015/18317610/112015.pdf

M. B. Yin, B. Guo, A. Panadero, C. Frank, C. Wrzosek et al., Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex, Exp Cell Res, vol.247, pp.189-199, 1999.

M. T. Yip-schneider, W. Miao, A. Lin, D. S. Barnard, G. Tzivion et al., Regulation of the Raf-1 kinase domain by phosphorylation, pp.14-17, 2000.

, Biochem J, vol.351, pp.151-159

A. Yoshimura, E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski et al., Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2, J Immunol, vol.163, pp.1-5, 1999.

P. Youinou, C. Jamin, and P. M. Lydyard, CD5 expression in human B-cell populations, Immunol Today, vol.20, pp.312-316, 1999.

M. R. Yuille, E. Matutes, A. Marossy, B. Hilditch, D. Catovsky et al., Familial chronic lymphocytic leukaemia: a survey and review of published studies, Br J Haematol, vol.109, pp.794-799, 2000.

K. A. Zarember and P. J. Godowski, Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines, J Immunol, vol.168, pp.554-561, 2002.

G. Zhang and S. Ghosh, Negative regulation of toll-like receptor-mediated signaling by Tollip, J Biol Chem, vol.277, pp.7059-7065, 2002.

R. K. Zhong, A. D. Donnenberg, H. F. Zhang, S. Watkins, J. H. Zhou et al., Human blood dendritic cell-like B cells isolated by the 5G9 monoclonal antibody reactive with a novel 220-kDa antigen, J Immunol, vol.163, pp.1354-1362, 1999.

M. T. Zilber, S. Gregory, R. Mallone, S. Deaglio, F. Malavasi et al., CD38 expressed on human monocytes: a coaccessory molecule in the superantigen-induced proliferation, Proc Natl Acad Sci U S A, vol.97, pp.2840-2845, 2000.

H. Zou, Y. Li, X. Liu, and X. Wang, An APAF-1·Cytochrome c Multimeric Complex Is a Functional Apoptosome That Activates Procaspase-9, J Biol Chem, vol.274, pp.11549-11556, 1999.

A. Zucchetto, P. Sonego, M. Degan, R. Bomben, M. Dal-bo et al., Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance, J Immunol Methods, vol.305, pp.20-32, 2005.

S. Zwaveling, F. Mota, S. C. Nouta, J. Johnson, M. Lipford et al., Established human papillomavirus type 16expressing tumors are effectively eradicated following vaccination with long peptides, J Immunol, vol.169, pp.350-358, 2002.